The report on Insulin Delivery System by Infinium Global Research analyses the Insulin Delivery System Market over the period of 2017 to 2023. Moreover, the IGR-Growth Matrix given in the report provides key focus areas and investment areas the market players can focus on. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017 to 2023.
Get Sample Copy of this Report:
According to the report, the global insulin delivery system market is anticipated to reach to USD 13.84 billion in 2023. The report identified that the global market for insulin delivery systems was dominated by the Americas region followed by the Europeaninsulin delivery system market in 2015 and 2016. On the basis of countries, the U.S. led the global insulin delivery system market due to improvement in healthcare scheme such as offering compensation. Patient are moving from hospitals to speciality clinics, User prefer syringes and insulin pens because of their low cost, refining policies for compensation, and availability, affordability of devices, are some of the key factor driving the growth of global insulin delivery system market Moreover, needle nervousness in patients affect the growth of the pen needles and syringes market, and, problems related with the reuse of pen needles and infusion sets are the key factors restraining the growth of this market.
Get 15% discount for early purchase of “global Insulin delivery system market by region (North America, Europe, Asia Pacific, Latin America and RoW)” report on
Growing research and development, increasing expenditure in emerging economies on diabetes-related health are likely to bring more opportunities to this market.
The report segments the global insulin delivery system market in terms of product types and applications. Among the product type the insulin pen accounted for the largest share over the period of 2015 and 2016.
The companies covered in the report include ELI Lilly and Company, Ypsomed Holding AG, Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc., Medtronic PLC, Sanofi, Animas Corporation (Johnson and Johnson), Insulet Corporation, Biocon Limited.
Make an Enquiry @
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.